Who owns Celldex Therapeutics?
Key information on Celldex Therapeutics (Ticker: CLDX)
- CUSIP: 15117B103
Who owns Celldex Therapeutics?
Is CLDX a good stock to own? Find out who bought Celldex Therapeutics, who sold Celldex Therapeutics (CLDX) stock, and who holds a large position in Celldex Therapeutics.
- Franklin Resources owns 5.02M shares worth $58.17M
- Jennison Associates owns 4.59M shares worth $53.16M
- S.A.C. Capital Advisors owns 3.93M shares worth $45.52M
- Ridgeback Capital Investments owns 2.86M shares worth $18.02M
- STATE STREET CORPORATION owns 2.72M shares worth $31.51M
- Columbus Circle Investors owns 2.64M shares worth $30.57M
- HealthCor Management owns 2.50M shares worth $8.88M
- Vanguard owns 2.11M shares worth $24.39M
- HealthCor Management owns 2.00M shares worth $23.16M
- Wellington Management Company owns 1.62M shares worth $18.80M
- TimesSquare Capital Management owns 1.35M shares worth $15.64M
- TSP Capital Management owns 1.29M shares worth $14.90M
- First Eagle Investment Management owns 1.23M shares worth $14.24M
- ALLIANCEBERNSTEIN owns 1.17M shares worth $13.59M
- Millennium Management owns 847592 shares worth $9.82M
- Soros Fund Management owns 803200 shares worth $4.09M
- Ayer Capital Management owns 614200 shares worth $3.13M
- CITADEL ADVISORS owns 585757 shares worth $6.78M
- Private Capital Advisors owns 541000 shares worth $6.26M
- Technical Financial Services owns 502209 shares worth $2.56M
- JPMORGAN CHASE & CO owns 478860 shares worth $2.48M
- Oxford Asset Management owns 475656 shares worth $3.19M
- D. E. Shaw & Co owns 461989 shares worth $5.35M
- TIAA-CREF Investment Management owns 409883 shares worth $4.75M
- SMITH ASSET MANAGEMENT owns 391711 shares worth $18.76B
- TCW owns 386141 shares worth $4.47M
- Deerfield Management Company owns 345936 shares worth $4.01M
- Abingworth owns 343396 shares worth $1.75M
- Balyasny Asset Management owns 325000 shares worth $1.65M
- Geode Capital Management owns 315440 shares worth $3.65M
- Royce & Associates owns 300000 shares worth $3.47M
- Bailard owns 275000 shares worth $1.42M
- Jefferies owns 257980 shares worth $1.74M
- WALL STREET ASSOCIATES owns 242471 shares worth $2.81M
- Eudaimonia Asset Management owns 235209 shares worth $2.72M
- UBS AG owns 213869 shares worth $1.44M
- Frank Russell Company owns 212089 shares worth $2.38M
- CalPERS owns 199254 shares worth $2.31M
- Allianz Asset Management AG owns 190100 shares worth $2.20M
- NUMERIC INVESTORS owns 181900 shares worth $940423
- Suffolk Capital Management owns 180100 shares worth $2.09M
- Charles Schwab Bank owns 177174 shares worth $15.30M
- Charles Schwab Investment Management owns 176836 shares worth $1.98M
Who sold Celldex Therapeutics?
- Barclays sold on June 30, 2011
- Brighton Jones sold on June 30, 2011
- GOLDMAN SACHS sold on June 30, 2011
- CQS Cayman Limited Partnership sold on June 30, 2010
Funds that own CLDX also own:
- Goldman Sachs (GS)
- MasterCard Incorporated (MA)
- Costco Wholesale Corporation (COST)
- Crown Castle International (CCI)
- Monsanto Company (MON)
- BioMarin Pharmaceutical (BMRN)
- Vertex Pharmaceuticals Incorporated (VRTX)
- Walt Disney Company (DIS)
- Bristol Myers Squibb (BMY)
- Heartland Express (HTLD)
- Union Pacific Corporation (UNP)
- Global Payments (GPN)
- Boeing Company (BA)
- LifePoint Hospitals (LPNT)
- Red Hat (RHT)
- Allergan (AGN)
- Apple (AAPL)
- International Business Machines (IBM)
- NIKE (NKE)
- United Technologies Corporation (UTX)
- UnitedHealth (UNH)